Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous diphenhydramine for pain, agitation, nausea, and vomiting after bariatric surgery
IRCT20130304012695N6Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of diphenhydramine in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Incidence of postoperative pain, Incidence of postoperative agitation and 4 more. Started Apr 2019; status: completed.
02
Drugs
diphenhydramine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20130304012695N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130304012695N6.